Showing 51-60 of 8793 results for "".
Questions on Established Patients, Medicare Services for Families, and Coding for Destructions
https://practicaldermatology.com/topics/practice-management/questions-on-established-patients-medicare-services-for-families-and-coding-for-destructions/21667/Seeing new patients doesn't necessarily provide better reimbursement than Established Patients. Here are answers to questions on this and other coding matters.Revisiting Cyclosporine in the Age of Biologics: Update on Efficacy and Mechanism of Action
https://practicaldermatology.com/topics/general-topics/revisiting-cyclosporine-in-the-age-of-biologics-update-on-efficacy-and-mechanism-of-action/21937/Increased understanding of the immunologic basis of psoriasis supports the role of cyclosporine in patient management.A Mainstay in Treating Acne: The Role of Benzoyl Peroxide
https://practicaldermatology.com/topics/acne-rosacea/a-mainstay-in-treating-acne-the-role-of-benzoyl-peroxide/23307/Products like La Roche-Posay’s Effaclar Duo are effective in the management of acne.Can Prescription Hyperhidrosis Treatments Help Mitigate Symptoms?
https://practicaldermatology.com/issues/novemberdecember-2025/can-prescription-hyperhidrosis-treatments-help-mitigate-symptoms/48890/Clinicians should begin to think beyond standard protocols and recognize sweat management as a potentially powerful tool in their therapeutic arsenal.Fine Particulate Matter and Eczema
https://practicaldermatology.com/issues/july-2025/fine-particulate-matter-and-eczema/36512/The primary objective of this study was to investigate the potential associations between fine particulate matter (specifically PM2.5) exposure and eczema. Researchers on this study set out to explore whether the odds of having eczema would increase with greater PM2.5 exposure, and to identify whethThe Microbiome in Atopic Dermatitis: Where Are We Now?
https://practicaldermatology.com/topics/atopic-dermatitis/the-microbiome-in-atopic-dermatitis-where-are-we-now/23746/It seems increasingly likely that microbes will play a central role in understanding AD and its treatments.Taking a More Holistic View of the Pathogenesis of Acne
https://practicaldermatology.com/topics/acne-rosacea/taking-more-holistic-view-pathogenesis-acne/26539/Taking a More Holistic View of the Pathogenesis of AcneLook to the EAST: Shared Decision Making in the Era of New Therapies
https://practicaldermatology.com/topics/atopic-dermatitis/look-to-the-east-shared-decision-making-in-the-era-of-new-therapies/23372/Assessing Efficacy, Accessibility, Safety, and Tolerability is the key to a meaningful dialogue with patients.Cutaneous Metastasis of Adenocarcinoma with an Unknown Primary Tumor
https://practicaldermatology.com/youngmd-connect/resident-resource-center/cutaneous-metastasis-of-adenocarcinoma-with-an-unknown-primary-tumor/20352/Report and discussion: Cutaneous metastasis of adenocarcinoma with an unknown primary tumor.Maximizing Valuation and Outcomes for Practice Owners: A Conversation with Dana Jacoby
https://practicaldermatology.com/topics/practice-management/maximizing-valuation-and-outcomes-for-practice-owners-a-conversation-with-dana-jacoby/29889/Contributor Clint Bundy recently interviewed Dana Jacoby, President and CEO of Vector Medical Group, an operational and strategic consulting firm focused on the healthcare sector, to discuss building value in a dermatology and aesthetics practice and optimal ways to achieve full value for that busin